Tirzepatide is a medication that may produce weight loss and improve blood glucose control in adults with type 2 diabetes, obesity, or overweight
Its reputation comes from how frequently it appears in experiments centered on resilience, cellular restoration, and localized response mechanisms
Miriam Sandn reports (a) honoraria for lectures from AstraZeneca, Ferrer, Novo Nordisk, Sanofi and Amgen
Tell your healthcare provider if you are taking medicines to treat diabetes including insulin or sulfonylureas which could increase your risk of low blood sugar
If sweating or other side effects become intolerable despite these measures, discuss with your doctor whether temporarily maintaining your current dose, slowing the titration schedule, or considering alternative treatments might be appropriate
The GPX4 inhibitors could downregulate GPX4 and selectively reduce the residual CRC persister cell pool in vitro